Shakevia Johnson

Mechanistic Role for a Novel Glucocorticoid-KLF11 (TIEG2) Protein Pathway in Stress-induced Monoamine Oxidase A Expression

Matthew Grunewald, Shakevia Johnson, Deyin Lu et al. · Journal of Biological Chemistry · 2012 · 104 citations · Full text

Reductive Stress, Mechanistic Role, Novel Glucocorticoid-klf11 +8

The Reduction of R1, a Novel Repressor Protein for Monoamine Oxidase A, in Major Depressive Disorder

Shakevia Johnson, Craig A. Stockmeier, Jeffrey H. Meyer et al. · Neuropsychopharmacology · 2011 · 84 citations · Full text

Psychiatry, Biochemistry, Protein Folding +10

Comparative Neuroprotective Effects of Rasagiline and Aminoindan with Selegiline on Dexamethasone-Induced Brain Cell Apoptosis

Shawna Tazik, Shakevia Johnson, Deyin Lu et al. · Neurotoxicity Research · 2009 · 52 citations · Full text

Comparative Neuroprotective Effects, Medicine, Pharmacology +9

Evidence Revealing Deregulation of The KLF11-Mao A Pathway in Association with Chronic Stress and Depressive Disorders

Sharonda Harris, Shakevia Johnson, Jeremy W. Duncan et al. · Neuropsychopharmacology · 2014 · 41 citations · Full text

Chronic Stress, Depressive Disorders, Psychoneuroimmunology +12

The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis

Shakevia Johnson, Shawna Tazik, Deyin Lu et al. · Frontiers in Neuroscience · 2010 · 31 citations · Full text

Cell Death, Mao Activity, Pharmacotherapy +17